The World Health Organization has declared the new Ebola outbreak in the Democratic Republic of Congo a public health emergency of international concern. WHO Director‑General Tedros Adhanom Ghebreyesus said the decision was made to coordinate a global response, but emphasized the situation “does not meet the criteria of pandemic emergency” and urged countries not to close their borders.
Health authorities first reported the outbreak in late April in Ituri province in eastern DRC. Officials have identified hundreds of suspected cases, and one confirmed fatal case crossed into neighboring Uganda. The Africa Centres for Disease Control and Prevention (Africa CDC) has said the virus involved is the Bundibugyo strain, for which there is currently no licensed vaccine.
Bundibugyo is less common than the Zaire strain and therefore less well understood. Africa CDC director Dr. Jean Kaseya said in a video press briefing that the outbreak likely began in late April; as of his remarks there were 336 suspected cases and 87 deaths. Most detections so far are clustered in two mining towns, Mongwalu and Rwampara, areas where labor migration and frequent travel increase the risk of wider spread.
Ebola spreads through direct contact with blood or other bodily fluids, or via contaminated surfaces. Typical symptoms include fever, body aches, weakness and vomiting, and some patients may experience bleeding. Because the disease can transmit readily in close‑contact settings, infectious disease experts stress strict protective measures for health workers: head coverings, goggles, masks or face shields, gloves, gowns and, in some settings, rubber boots.
On May 14 a 59‑year‑old Congolese man who had traveled from the DRC died in a hospital in Kampala, Uganda. Kaseya described how the man had taken public transportation, sought care in Uganda and was treated by people in the community before he died; his body was subsequently taken back across the border to the DRC for burial. Authorities are investigating contacts and the protective equipment used by those who interacted with him.
There have been two prior outbreaks of the Bundibugyo strain, but no established vaccine exists for it. Researchers are studying a candidate experimental vaccine that has been tested in nonhuman primates and, according to Kaseya, has shown roughly 50% efficacy in those trials; its safety and effectiveness in humans have not yet been established.
Africa CDC said it is working with WHO, national health agencies, nonprofits and pharmaceutical partners to strengthen cross‑border surveillance, preparedness and response measures. Public health specialists warn that the outbreak appears to have been spreading for some time before detection; as Dr. Craig Spencer, a public‑health professor who survived Ebola infection in 2014, noted, delayed recognition makes contact tracing and containment much harder.
The declaration recalls the scale of past Ebola crises: during the 2014–2016 West Africa epidemic, roughly 28,600 people were infected and about 11,325 died, underscoring why rapid coordination and protective measures are being prioritized now.